Catalent Biologics Restructures Biologics Business
US drugmaker Catalent announced key organizational changes within its biologics business.
Tedd Green, former president of Cook Pharmica, has been appointed as senior vice president of Catalent Biologics, and will have responsibility for the entire biologics business. In this role he will also act as a member of Catalent’s executive leadership team. Green will be based at the Bloomington facility.
Mike Riley has been appointed as vice president and general manager of Drug Substance and Bioanalytical services for Catalent Biologics. He will lead the company’s biologics manufacturing business based at several sites across Catalent’s global network.
Cory Lewis will take on the new role of vice president and general manager of the company’s Drug Product business, with a focus on growing the drug product offerings both in the US and in Europe.
In a further move, Ryan Hawkins has been appointed as general manager of the Bloomington site.